RecruitingNCT06694792

Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium

Studying Intraductal papillary mucinous carcinoma of pancreas

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IRCCS San Raffaele
Enrollment
800 target
Eligibility
18 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

University of Pisa · Casa Sollievo della Sofferenza IRCCS · The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06694792 on ClinicalTrials.gov

Other trials for Intraductal papillary mucinous carcinoma of pancreas

Additional recruiting or active studies for the same condition.

See all trials for Intraductal papillary mucinous carcinoma of pancreas

← Back to all trials